Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
44 hedge funds and large institutions have $35.2M invested in Calithera Biosciences, Inc in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 18 closing their positions.
3,700% more call options, than puts
Call options by funds: $38K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 52 → 44 (-8)
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
43% less capital invested
Capital invested by funds: $62.1M → $35.2M (-$26.9M)
61% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$401K |
| 2 |
Millennium Management
New York
|
+$384K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$266K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$207K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.14M |
| 2 |
JP Morgan Chase
New York
|
-$1.33M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$632K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$462K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Charles Schwab
San Francisco,
California
| – | -$108K | -950 | Closed |
|
52
RhumbLine Advisers
Boston,
Massachusetts
| – | -$91K | -805 | Closed |
|
53
LPL Financial
San Diego,
California
| – | -$73K | -641 | Closed |
|
54
Balyasny Asset Management
Chicago,
Illinois
| – | -$60K | -530 | Closed |
|
55
New York State Common Retirement Fund
Albany,
New York
| – | -$57K | -505 | Closed |
|
56
Citigroup
New York
| – | -$45K | -395 | Closed |
|
|
AIG
57
American International Group
New York
| – | -$37K | -324 | Closed |
|
58
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$21.7K | -217 | -98% |
|
59
Simplex Trading
Chicago,
Illinois
| – | -$13.3K | -133 | Closed |
|
60
Group One Trading
Chicago,
Illinois
| – | -$4.51K | -45 | Closed |
|
|
QCG
61
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$4K | -43 | Closed |
|
62
BlackRock
New York
| – | -$2K | -19 | Closed |
|
CALA Hedge Fund Activity: Q2 2016 in Review
44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2016, worth a combined $35.2M — down 43% from $62.1M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CALA and 11 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 7 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $401K. The largest seller was Fidelity Investments, cutting an estimated $3.14M.
- 44 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2016, down from 52 in Q1 2016.
- Funds reported $35.2M of Calithera Biosciences, Inc stock for Q2 2016, down 43% quarter-over-quarter.
- 11 funds opened new Calithera Biosciences, Inc positions in Q2 2016 and 18 closed out, a net change of -7 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2016 was Bridgeway Capital Management, an estimated $401K added.
- The largest Calithera Biosciences, Inc seller in Q2 2016 was Fidelity Investments, an estimated $3.14M sold.
Based on aggregated 13F filings for Q2 2016.